Cardiotoxicity from intensive chemotherapy combined with radiotherapy in breast cancer
1997

Cardiotoxicity from Intensive Chemotherapy and Radiotherapy in Breast Cancer

Sample size: 86 publication Evidence: moderate

Author Information

Author(s): H de Graaf, WV Dolsma, PHB Willemsel, WTA van der Graaf, DTh Sleijfer, EGE de Vries, NH Mulder

Primary Institution: University Hospital Groningen, The Netherlands

Hypothesis

What are the long-term effects of intensive chemotherapy combined with radiotherapy on cardiac function in breast cancer patients?

Conclusion

The study found that life-threatening cardiotoxicity is rare, with 78% of patients free of cardiac dysfunction at 7 years.

Supporting Evidence

  • One patient died of subacute heart failure 3 months after ablative chemotherapy.
  • At a minimum of 1 year's follow-up, left ventricular ejection fraction (LVEF) was marginally abnormal in 4 of 27 disease-free survivors.
  • 78% of patients were free of clinical and subclinical cardiac dysfunction at 7 years.

Takeaway

Doctors looked at how chemotherapy and radiation affect the hearts of women with breast cancer. Most of them didn't have serious heart problems after treatment.

Methodology

Cardiac function was evaluated using left ventricular ejection fraction (LVEF) measurements in breast cancer patients after treatment.

Limitations

The study had a limited follow-up period and a small number of events.

Participant Demographics

Eighty-six premenopausal patients with locally advanced or disseminated breast cancer, median age 42 years.

Statistical Information

Confidence Interval

95% CI 61-95%

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication